
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="Clinical decision support for migraine with aura diagnosis and management, including differentiation from TIA/stroke and contraceptive considerations">
      
      
      
        <link rel="canonical" href="https://blondarb.github.io/neuro-plans/drafts/migraine-with-aura/">
      
      
      
      
        
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.7.1">
    
    
      
        <title>Migraine with Aura - Neuro Clinical Plans</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.484c7ddc.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.ab4e12ef.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../assets/css/custom.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#migraine-with-aura" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Neuro Clinical Plans" class="md-header__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Neuro Clinical Plans
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              Migraine with Aura
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a4 4 0 0 0-4 4 4 4 0 0 0 4 4 4 4 0 0 0 4-4 4 4 0 0 0-4-4m0 10a6 6 0 0 1-6-6 6 6 0 0 1 6-6 6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 18c-.89 0-1.74-.2-2.5-.55C11.56 16.5 13 14.42 13 12s-1.44-4.5-3.5-5.45C10.26 6.2 11.11 6 12 6a6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
        <div class="md-search__suggest" data-md-component="search-suggest"></div>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Neuro Clinical Plans" class="md-nav__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    Neuro Clinical Plans
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Home
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../clinical/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Interactive Clinical Tool
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3" >
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    Clinical Plans
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Clinical Plans
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_2" >
        
          
          <label class="md-nav__link" for="__nav_3_2" id="__nav_3_2_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Seizures & Epilepsy
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_2">
            <span class="md-nav__icon md-icon"></span>
            
  
    Seizures & Epilepsy
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/status-epilepticus/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Status Epilepticus
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/new-onset-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    New Onset Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/breakthrough-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Breakthrough Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_3" >
        
          
          <label class="md-nav__link" for="__nav_3_3" id="__nav_3_3_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Stroke & Vascular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Stroke & Vascular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-ischemic-stroke/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Ischemic Stroke
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/transient-ischemic-attack/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Transient Ischemic Attack
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/intracerebral-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Intracerebral Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/subarachnoid-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Subarachnoid Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_4" >
        
          
          <label class="md-nav__link" for="__nav_3_4" id="__nav_3_4_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuromuscular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/guillain-barre-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Guillain-Barré Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-crisis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenic Crisis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/myasthenia-gravis-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenia Gravis - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/neuromuscular-respiratory-failure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular Respiratory Failure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/peripheral-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Peripheral Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_5" >
        
          
          <label class="md-nav__link" for="__nav_3_5" id="__nav_3_5_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    CNS Infections
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_5_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_5">
            <span class="md-nav__icon md-icon"></span>
            
  
    CNS Infections
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bacterial-meningitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bacterial Meningitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/hsv-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    HSV Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/autoimmune-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Autoimmune Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_6" >
        
          
          <label class="md-nav__link" for="__nav_3_6" id="__nav_3_6_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Spinal Emergencies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_6_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_6">
            <span class="md-nav__icon md-icon"></span>
            
  
    Spinal Emergencies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/acute-myelopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Myelopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/spinal-cord-compression-malignant/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Spinal Cord Compression (Malignant)
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/cauda-equina-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cauda Equina Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/epidural-abscess/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Epidural Abscess
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_7" >
        
          
          <label class="md-nav__link" for="__nav_3_7" id="__nav_3_7_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuro-Oncology
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_7_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_7">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuro-Oncology
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/brain-metastases/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Brain Metastases
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_8" >
        
          
          <label class="md-nav__link" for="__nav_3_8" id="__nav_3_8_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Critical Care
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_8_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_8">
            <span class="md-nav__icon md-icon"></span>
            
  
    Critical Care
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/elevated-icp-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Elevated ICP Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_9" >
        
          
          <label class="md-nav__link" for="__nav_3_9" id="__nav_3_9_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Demyelinating
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_9_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_9">
            <span class="md-nav__icon md-icon"></span>
            
  
    Demyelinating
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/ms-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_10" >
        
          
          <label class="md-nav__link" for="__nav_3_10" id="__nav_3_10_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Headache
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_10_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_10">
            <span class="md-nav__icon md-icon"></span>
            
  
    Headache
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/migraine/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Migraine
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_11" >
        
          
          <label class="md-nav__link" for="__nav_3_11" id="__nav_3_11_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Movement Disorders
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_11_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_11">
            <span class="md-nav__icon md-icon"></span>
            
  
    Movement Disorders
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/parkinsons-disease-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Parkinson's Disease - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/essential-tremor/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Essential Tremor
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_12" >
        
          
          <label class="md-nav__link" for="__nav_3_12" id="__nav_3_12_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Dementia & Cognitive
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_12_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_12">
            <span class="md-nav__icon md-icon"></span>
            
  
    Dementia & Cognitive
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/dementia-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Dementia Evaluation
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/rapidly-progressive-dementia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Rapidly Progressive Dementia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_13" >
        
          
          <label class="md-nav__link" for="__nav_3_13" id="__nav_3_13_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Cranial Neuropathies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_13_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_13">
            <span class="md-nav__icon md-icon"></span>
            
  
    Cranial Neuropathies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/bells-palsy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bell's Palsy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_14" >
        
          
          <label class="md-nav__link" for="__nav_3_14" id="__nav_3_14_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Other
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_14_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_14">
            <span class="md-nav__icon md-icon"></span>
            
  
    Other
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../plans/vertigo-dizziness-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Vertigo / Dizziness
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    References
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    References
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/lp-reference/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    LP Reference
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/tracker/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Template Tracker
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#section-a-action-items" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION A: ACTION ITEMS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#section-b-reference" class="md-nav__link">
    <span class="md-ellipsis">
      
        SECTION B: REFERENCE
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#change-log" class="md-nav__link">
    <span class="md-ellipsis">
      
        CHANGE LOG
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-a-aura-types-and-characteristics" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX A: Aura Types and Characteristics
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#appendix-b-contraceptive-guidance-for-migraine-with-aura" class="md-nav__link">
    <span class="md-ellipsis">
      
        APPENDIX B: Contraceptive Guidance for Migraine with Aura
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              
              <article class="md-content__inner md-typeset">
                
                  

  <nav class="md-tags" >
    
      
      
      
      
        <a href="../../tags/#tag:aura" class="md-tag">aura</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:emergency" class="md-tag">emergency</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:headache" class="md-tag">headache</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:migraine" class="md-tag">migraine</a>
      
    
      
      
      
      
        <a href="../../tags/#tag:outpatient" class="md-tag">outpatient</a>
      
    
  </nav>


  
  


<div class="draft-warning-banner">
  <div class="icon">⚠️</div>
  <div class="content">
    <div class="title">DRAFT - Pending Review</div>
    <div class="description">This plan requires physician review before clinical use.</div>
  </div>
</div>

<h1 id="migraine-with-aura">Migraine with Aura<a class="headerlink" href="#migraine-with-aura" title="Permanent link">&para;</a></h1>
<p><strong>DIAGNOSIS:</strong> Migraine with Aura
<strong>ICD-10:</strong> G43.109 (Migraine with aura, not intractable, without status migrainosus)
<strong>SCOPE:</strong> Diagnosis and management of migraine with typical aura (visual, sensory, language) and hemiplegic migraine. Focuses on outpatient management with acute care considerations. Covers differentiation from TIA/stroke, contraceptive counseling, and preventive therapy. Excludes migraine with brainstem aura (separate protocol) and retinal migraine.</p>
<p><strong>STATUS:</strong> Draft - Pending Review</p>
<hr />
<p><strong>PRIORITY KEY:</strong> STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting</p>
<p><strong>CLINICAL NOTES:</strong>
- Aura typically precedes headache by 5-60 minutes but can occur during or without headache
- <strong>Triptans ARE safe in typical migraine with aura</strong> (visual, sensory, language)
- <strong>Triptans/ergots CONTRAINDICATED in hemiplegic migraine</strong> (motor aura)
- <strong>Estrogen-containing contraceptives contraindicated</strong> - elevated ischemic stroke risk
- Always differentiate from TIA/stroke on first presentation</p>
<hr />
<h2 id="section-a-action-items">SECTION A: ACTION ITEMS<a class="headerlink" href="#section-a-action-items" title="Permanent link">&para;</a></h2>
<hr />
<h2 id="1-laboratory-workup">1. LABORATORY WORKUP<a class="headerlink" href="#1-laboratory-workup" title="Permanent link">&para;</a></h2>
<h3 id="1a-essentialcore-labs">1A. Essential/Core Labs<a class="headerlink" href="#1a-essentialcore-labs" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>CBC</td>
<td>Rule out anemia, infection; baseline before treatment</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>BMP</td>
<td>Electrolyte abnormalities; renal function for medication dosing</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Glucose</td>
<td>Hypoglycemia can mimic aura; hyperglycemia raises stroke risk</td>
<td>70-180 mg/dL</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>PT/INR, PTT</td>
<td>Coagulation screen if stroke consideration; before LP</td>
<td>Normal</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>HbA1c</td>
<td>Vascular risk assessment</td>
<td>&lt;7% optimal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Lipid panel</td>
<td>Vascular risk stratification</td>
<td>LDL &lt;100 mg/dL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="1b-extended-workup-second-line">1B. Extended Workup (Second-line)<a class="headerlink" href="#1b-extended-workup-second-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>ESR, CRP</td>
<td>Rule out GCA if age &gt;50 with new visual symptoms</td>
<td>Normal</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>TSH</td>
<td>Thyroid dysfunction can trigger headache/aura-like symptoms</td>
<td>Normal (0.4-4.0 mIU/L)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Magnesium (RBC)</td>
<td>Deficiency linked to migraine with aura specifically</td>
<td>&gt;4.2 mg/dL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Homocysteine</td>
<td>Elevated levels associated with migraine with aura and stroke</td>
<td>&lt;15 μmol/L</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin B12, folate</td>
<td>Deficiency can elevate homocysteine; sensory symptoms</td>
<td>Normal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Vitamin D, 25-OH</td>
<td>Deficiency associated with increased migraine frequency</td>
<td>&gt;30 ng/mL</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="1c-rarespecialized-refractory-or-atypical">1C. Rare/Specialized (Refractory or Atypical)<a class="headerlink" href="#1c-rarespecialized-refractory-or-atypical" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th>Rationale</th>
<th>Target Finding</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-β2GP1)</td>
<td>Thrombophilia workup if young stroke or recurrent prolonged aura</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Factor V Leiden, prothrombin G20210A</td>
<td>Hereditary thrombophilia if recurrent aura or stroke-like events</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>ANA, anti-dsDNA</td>
<td>CNS lupus in atypical presentations</td>
<td>Negative</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MTHFR mutation</td>
<td>Elevated homocysteine with aura</td>
<td>Wild type or heterozygous</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Genetic testing (CACNA1A, ATP1A2, SCN1A)</td>
<td>Hemiplegic migraine suspected; family history</td>
<td>Variant identified</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CSF analysis</td>
<td>Rule out meningitis, SAH if atypical presentation</td>
<td>Normal; no xanthochromia</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="2-diagnostic-imaging-studies">2. DIAGNOSTIC IMAGING &amp; STUDIES<a class="headerlink" href="#2-diagnostic-imaging-studies" title="Permanent link">&para;</a></h2>
<h3 id="2a-essentialfirst-line">2A. Essential/First-line<a class="headerlink" href="#2a-essentialfirst-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI Brain without contrast</td>
<td>First presentation with aura; rule out stroke/structural lesion</td>
<td>Normal; no acute infarct; no WMH concerning for vasculopathy</td>
<td>MRI-incompatible devices</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CT Head non-contrast</td>
<td>Acute presentation if MRI unavailable; rule out hemorrhage</td>
<td>No hemorrhage or mass</td>
<td>Pregnancy (relative)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MRA Head</td>
<td>First aura or prolonged aura to assess intracranial vessels</td>
<td>No stenosis, aneurysm, or dissection</td>
<td>MRI contraindications</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="2b-extended">2B. Extended<a class="headerlink" href="#2b-extended" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI Brain with contrast</td>
<td>Atypical features; persistent deficits; concern for mass</td>
<td>No enhancement; no mass</td>
<td>Gadolinium allergy; severe renal impairment</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MRA Neck</td>
<td>Suspected cervical dissection (neck pain, Horner syndrome)</td>
<td>No dissection</td>
<td>MRI contraindications</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CTA Head/Neck</td>
<td>Acute vascular imaging if MRI unavailable</td>
<td>No aneurysm, dissection, occlusion</td>
<td>Contrast allergy; CKD (eGFR &lt;30)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>TTE with bubble study</td>
<td>Evaluate for PFO if recurrent aura or cryptogenic stroke history</td>
<td>No PFO; if present, assess shunt size</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="2c-rarespecialized">2C. Rare/Specialized<a class="headerlink" href="#2c-rarespecialized" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>TEE</td>
<td>Detailed cardiac source evaluation if TTE positive or high suspicion</td>
<td>No cardiac thrombus; characterize PFO</td>
<td>Esophageal pathology</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>MRI with perfusion/DWI</td>
<td>Prolonged aura to differentiate migrainous infarct from stroke</td>
<td>No DWI restriction</td>
<td>MRI contraindications</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Transcranial Doppler with bubble</td>
<td>PFO screening; noninvasive alternative to TTE bubble</td>
<td>No right-to-left shunt</td>
<td>Inadequate acoustic windows</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>EEG</td>
<td>Aura with altered consciousness; differentiate from seizure</td>
<td>No epileptiform activity</td>
<td>None</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="3-treatment">3. TREATMENT<a class="headerlink" href="#3-treatment" title="Permanent link">&para;</a></h2>
<h3 id="3a-acuteemergent">3A. Acute/Emergent<a class="headerlink" href="#3a-acuteemergent" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ketorolac</td>
<td>IV/IM</td>
<td>First-line acute migraine with aura in ED</td>
<td>30 mg IV x1; 15 mg IV x1 :: IV :: :: 30 mg IV (15 mg if &gt;65y, renal impairment, or &lt;50 kg); max 5 days NSAIDs</td>
<td>Renal impairment (CrCl &lt;30); active GI bleed; aspirin/NSAID allergy; third trimester</td>
<td>Renal function if repeated dosing</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Metoclopramide</td>
<td>IV</td>
<td>Antiemetic with anti-migraine properties</td>
<td>10 mg IV over 15 min; 20 mg IV over 15 min :: IV :: :: 10-20 mg IV over 15 min; pretreat with diphenhydramine 25 mg IV to prevent akathisia</td>
<td>Parkinson's disease; tardive dyskinesia history; bowel obstruction; pheochromocytoma</td>
<td>Akathisia, dystonia; discontinue if EPS</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Prochlorperazine</td>
<td>IV</td>
<td>Dopamine antagonist for acute migraine with prominent nausea</td>
<td>10 mg IV over 2 min :: IV :: :: 10 mg IV slowly over 2 min; pretreat with diphenhydramine 25 mg IV</td>
<td>QT prolongation (QTc &gt;500ms); Parkinson's disease; neuroleptic malignant syndrome history</td>
<td>QTc if baseline prolonged; EPS</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Diphenhydramine</td>
<td>IV</td>
<td>Prevent akathisia from dopamine antagonists; sedation</td>
<td>25 mg IV; 50 mg IV :: IV :: :: 25-50 mg IV given concurrently with dopamine antagonist</td>
<td>Narrow-angle glaucoma; urinary retention; severe prostatic hypertrophy</td>
<td>Sedation; anticholinergic effects</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Magnesium sulfate</td>
<td>IV</td>
<td>Migraine with aura - particularly effective; refractory migraine</td>
<td>2 g IV over 20 min :: IV :: :: 2 g IV in 50 mL NS over 20-30 min; may repeat x1 after 2 hr</td>
<td>Heart block; severe hypermagnesemia; myasthenia gravis; severe renal impairment</td>
<td>BP, HR during infusion; flushing is common and benign</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Sumatriptan</td>
<td>SC/PO</td>
<td>Acute migraine with TYPICAL aura (visual, sensory, language) - SAFE</td>
<td>6 mg SC x1; 50 mg PO x1; 100 mg PO x1 :: SC/PO :: :: 6 mg SC (may repeat after 1 hr, max 12 mg/24hr) OR 50-100 mg PO (may repeat after 2 hr, max 200 mg/24hr); take AFTER aura resolves or at headache onset</td>
<td><strong>HEMIPLEGIC MIGRAINE (motor aura)</strong>; uncontrolled HTN; CAD; prior stroke/TIA; MAOIs within 14 days; ergots within 24 hr</td>
<td>Chest tightness (triptan sensation vs cardiac); assess cardiovascular risk</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Valproate sodium</td>
<td>IV</td>
<td>Status migrainosus with aura; refractory to first-line</td>
<td>500 mg IV over 5 min; 1000 mg IV over 5 min :: IV :: :: 500-1000 mg IV over 5-10 min; may repeat 500 mg in 8 hr</td>
<td>Hepatic disease; pregnancy (teratogenic); urea cycle disorders; pancreatitis history</td>
<td>LFTs; ammonia if altered mental status</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Dexamethasone</td>
<td>IV</td>
<td>Prevent headache recurrence after acute treatment</td>
<td>10 mg IV x1 :: IV :: :: 10 mg IV x1 at time of discharge or admission; single dose</td>
<td>Active untreated infection; known hypersensitivity</td>
<td>Glucose if diabetic</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3b-symptomatic-treatments">3B. Symptomatic Treatments<a class="headerlink" href="#3b-symptomatic-treatments" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Rizatriptan</td>
<td>PO</td>
<td>Acute typical migraine with aura; fast onset</td>
<td>5 mg PO x1; 10 mg PO x1 :: PO :: :: 5-10 mg PO (use 5 mg if on propranolol); may repeat after 2 hr; max 30 mg/24hr</td>
<td>Same as sumatriptan; <strong>HEMIPLEGIC MIGRAINE</strong>; use 5 mg max if on propranolol</td>
<td>Triptan sensation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Eletriptan</td>
<td>PO</td>
<td>Acute typical migraine with aura; good for recurrence</td>
<td>40 mg PO x1; 80 mg PO x1 :: PO :: :: 40 mg PO; may repeat 40 mg after 2 hr if partial response; max 80 mg/24hr</td>
<td>Same as sumatriptan; <strong>HEMIPLEGIC MIGRAINE</strong>; potent CYP3A4 inhibitors (ketoconazole, clarithromycin)</td>
<td>Triptan sensation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Naratriptan</td>
<td>PO</td>
<td>Migraine with aura; longer duration; menstrual migraine</td>
<td>2.5 mg PO x1 :: PO :: :: 2.5 mg PO; may repeat after 4 hr; max 5 mg/24hr; slower onset but longer lasting</td>
<td>Same as sumatriptan; <strong>HEMIPLEGIC MIGRAINE</strong>; moderate-severe renal/hepatic impairment</td>
<td>Triptan sensation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Ubrogepant</td>
<td>PO</td>
<td>CGRP antagonist; use if triptan contraindicated or cardiovascular risk</td>
<td>50 mg PO x1; 100 mg PO x1 :: PO :: :: 50-100 mg PO; may repeat after 2 hr; max 200 mg/24hr</td>
<td>Strong CYP3A4 inhibitors; severe hepatic impairment</td>
<td>None routine; no cardiovascular contraindications</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Rimegepant</td>
<td>PO/ODT</td>
<td>CGRP antagonist; can use for acute and prevention</td>
<td>75 mg ODT x1 :: PO :: :: 75 mg ODT at onset; max 75 mg/24hr for acute; also approved 75 mg every other day for prevention</td>
<td>Strong CYP3A4 inhibitors/inducers; severe hepatic impairment</td>
<td>None routine</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Lasmiditan</td>
<td>PO</td>
<td>5-HT1F agonist; safe in cardiovascular disease; ditan class</td>
<td>50 mg PO x1; 100 mg PO x1; 200 mg PO x1 :: PO :: :: 50-200 mg PO x1; max 200 mg/24hr; DO NOT DRIVE for 8 hours after dose</td>
<td>Concurrent alcohol; CYP3A4 substrates with narrow TI</td>
<td>CNS depression; dizziness; NO driving for 8 hr</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Ibuprofen</td>
<td>PO</td>
<td>Mild-moderate aura migraine</td>
<td>400 mg PO x1; 600 mg PO x1; 800 mg PO x1 :: PO :: :: 400-800 mg PO at onset; max 2400 mg/day</td>
<td>Renal impairment; active GI bleed; aspirin/NSAID allergy; third trimester</td>
<td>GI symptoms; renal function if prolonged use</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Naproxen sodium</td>
<td>PO</td>
<td>Mild-moderate aura migraine; menstrual migraine prevention</td>
<td>550 mg PO x1 :: PO :: :: 550 mg PO at onset; may add 275 mg in 12 hr; max 1375 mg day 1, then 1100 mg/day</td>
<td>Renal impairment; active GI bleed; aspirin/NSAID allergy</td>
<td>GI symptoms</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Acetaminophen-Aspirin-Caffeine</td>
<td>PO</td>
<td>Mild-moderate migraine with aura (OTC option)</td>
<td>2 tablets PO x1 :: PO :: :: 2 tablets (250/250/65 mg each) at onset; max 2 doses/24hr</td>
<td>Aspirin allergy; hepatic impairment; avoid if using other acetaminophen sources</td>
<td>Limit total acetaminophen &lt;3 g/day</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Ondansetron</td>
<td>IV/PO</td>
<td>Nausea/vomiting with migraine</td>
<td>4 mg IV x1; 8 mg ODT x1 :: IV/PO :: :: 4 mg IV or 8 mg PO/ODT; may repeat q8h as needed</td>
<td>QT prolongation (QTc &gt;500ms); severe hepatic impairment</td>
<td>QTc if multiple doses or baseline prolongation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3c-second-linerefractory">3C. Second-line/Refractory<a class="headerlink" href="#3c-second-linerefractory" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Dihydroergotamine (DHE)</td>
<td>IV/SC/Nasal</td>
<td>Refractory migraine; status migrainosus; <strong>NOT for hemiplegic</strong></td>
<td>0.5 mg IV q8h; 1 mg SC x1; 1 spray per nostril :: IV/SC/Nasal :: :: IV: 0.5-1 mg q8h for up to 3 days (pretreat with antiemetic); SC: 1 mg, may repeat in 1 hr; Nasal: 1 spray each nostril, repeat in 15 min</td>
<td>Pregnancy; CAD; uncontrolled HTN; peripheral vascular disease; <strong>HEMIPLEGIC MIGRAINE</strong>; triptan use within 24hr; severe hepatic/renal impairment</td>
<td>BP; nausea; chest pain; continuous cardiac monitoring for IV</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Occipital nerve block</td>
<td>SC</td>
<td>Refractory migraine; occipital-predominant pain</td>
<td>Bupivacaine 0.5% 2-3 mL + triamcinolone 40 mg :: SC :: :: Inject at greater occipital nerve bilaterally; may add lesser occipital, supraorbital</td>
<td>Local anesthetic allergy; infection at injection site; anticoagulation (relative)</td>
<td>Vasovagal reaction; immediate pain assessment</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Ketamine</td>
<td>IV</td>
<td>Status migrainosus refractory to DHE</td>
<td>0.1-0.3 mg/kg/hr infusion :: IV :: :: 0.1-0.3 mg/kg/hr continuous infusion for 24-48 hr; subanesthetic dosing only</td>
<td>Uncontrolled HTN; psychosis history; elevated ICP; pregnancy</td>
<td>Dissociation; BP; HR; requires continuous cardiac monitoring</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Verapamil</td>
<td>IV</td>
<td>Hemiplegic migraine acute (if severe); status migrainosus</td>
<td>5 mg IV over 2 min :: IV :: :: 5 mg IV over 2-3 min; may repeat in 30 min (max 20 mg)</td>
<td>Heart block (2nd/3rd degree); severe LV dysfunction; hypotension</td>
<td>Continuous ECG; BP; for hemiplegic migraine when triptans contraindicated</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Intranasal lidocaine</td>
<td>Intranasal</td>
<td>Acute migraine with aura; rapid onset option</td>
<td>4% lidocaine 0.5 mL per nostril :: Intranasal :: :: 4% lidocaine, 0.5 mL per nostril directed at sphenopalatine fossa; may repeat x1 in 15 min</td>
<td>Local anesthetic allergy</td>
<td>Local numbness; cardiac arrhythmia (rare with low dose)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="3d-disease-modifying-or-chronic-therapies-preventive-medications">3D. Disease-Modifying or Chronic Therapies (Preventive Medications)<a class="headerlink" href="#3d-disease-modifying-or-chronic-therapies-preventive-medications" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Route</th>
<th>Indication</th>
<th>Dosing</th>
<th>Pre-Treatment Requirements</th>
<th>Contraindications</th>
<th>Monitoring</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Magnesium oxide</td>
<td>PO</td>
<td>First-line supplement for migraine with aura prevention</td>
<td>400 mg daily; 400 mg BID :: PO :: :: Start 400 mg daily; may increase to 400 mg BID; take with food to reduce GI upset</td>
<td>None</td>
<td>Renal impairment (CrCl &lt;30) - dose reduce</td>
<td>Diarrhea; check Mg level if symptomatic or renal disease</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Topiramate</td>
<td>PO</td>
<td>First-line oral prevention; reduces aura frequency; weight loss</td>
<td>25 mg qHS; 50 mg BID; 100 mg BID :: PO :: :: Start 25 mg qHS; increase by 25 mg/wk; target 50-100 mg BID</td>
<td>None</td>
<td><strong>PREGNANCY (teratogenic)</strong>; glaucoma; kidney stones; metabolic acidosis</td>
<td>Cognitive effects; paresthesias; weight; serum bicarbonate; kidney stones</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Propranolol</td>
<td>PO</td>
<td>First-line prevention; comorbid HTN, anxiety, tremor</td>
<td>40 mg BID; 80 mg BID; 80 mg LA daily; 160 mg LA daily :: PO :: :: Start 40 mg BID or 80 mg LA daily; titrate q2wk; target 80-240 mg/day</td>
<td>None</td>
<td>Asthma; COPD with bronchospasm; bradycardia &lt;50; 2nd/3rd degree heart block; decompensated HF</td>
<td>HR (goal &gt;50); BP; fatigue; depression; exercise intolerance</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Amitriptyline</td>
<td>PO</td>
<td>Prevention with comorbid insomnia, depression, tension-type headache</td>
<td>10 mg qHS; 25 mg qHS; 50 mg qHS; 75 mg qHS :: PO :: :: Start 10 mg qHS; titrate by 10-25 mg q1-2wk; target 25-75 mg qHS</td>
<td>ECG if &gt;50 y/o or cardiac history</td>
<td>Cardiac conduction disease; recent MI; glaucoma; urinary retention; elderly (anticholinergic burden)</td>
<td>Sedation; weight; dry mouth; ECG if dose &gt;100 mg or cardiac history</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Venlafaxine XR</td>
<td>PO</td>
<td>Prevention with comorbid depression, anxiety</td>
<td>37.5 mg daily; 75 mg daily; 150 mg daily :: PO :: :: Start 37.5 mg daily; increase by 37.5-75 mg q1wk; target 75-150 mg daily</td>
<td>None</td>
<td>Uncontrolled HTN; MAOIs within 14 days; abrupt discontinuation risk</td>
<td>BP at doses &gt;150 mg; serotonin syndrome signs; taper to discontinue</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Candesartan</td>
<td>PO</td>
<td>Prevention; comorbid HTN; beta-blocker intolerant</td>
<td>8 mg daily; 16 mg daily :: PO :: :: Start 8 mg daily; may increase to 16 mg daily after 4 wk</td>
<td>None</td>
<td><strong>Pregnancy</strong>; bilateral renal artery stenosis; hyperkalemia</td>
<td>BP; potassium; creatinine</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Valproate/Divalproex</td>
<td>PO</td>
<td>Prevention with comorbid bipolar or epilepsy</td>
<td>250 mg BID; 500 mg BID; 500 mg ER daily; 1000 mg ER daily :: PO :: :: Start 250 mg BID or 500 mg ER daily; titrate to 500-1000 mg/day</td>
<td>LFTs; CBC</td>
<td><strong>Pregnancy (teratogenic - neural tube defects)</strong>; hepatic disease; urea cycle disorders; pancreatitis history</td>
<td>LFTs q6mo; weight; hair loss; tremor; CBC</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Riboflavin (Vitamin B2)</td>
<td>PO</td>
<td>Supplement for prevention; well-tolerated; may reduce aura</td>
<td>400 mg daily :: PO :: :: 400 mg daily</td>
<td>None</td>
<td>None</td>
<td>Fluorescent yellow urine (reassure patient); benign</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Coenzyme Q10</td>
<td>PO</td>
<td>Supplement; mitochondrial support</td>
<td>100 mg TID; 300 mg daily :: PO :: :: 100-300 mg daily</td>
<td>None</td>
<td>None</td>
<td>None</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Erenumab (Aimovig)</td>
<td>SC</td>
<td>CGRP mAb; failed 2+ oral preventives or intolerance</td>
<td>70 mg SC monthly; 140 mg SC monthly :: SC :: :: 70 mg SC monthly; may increase to 140 mg monthly after 3 months if suboptimal response</td>
<td>None</td>
<td>Hypersensitivity to erenumab</td>
<td>Constipation (can be severe - may need laxatives); injection site reactions; HTN monitoring</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Fremanezumab (Ajovy)</td>
<td>SC</td>
<td>CGRP mAb; flexible dosing options</td>
<td>225 mg SC monthly; 675 mg SC quarterly :: SC :: :: 225 mg SC monthly OR 675 mg SC quarterly (three 225 mg injections)</td>
<td>None</td>
<td>Hypersensitivity</td>
<td>Injection site reactions</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Galcanezumab (Emgality)</td>
<td>SC</td>
<td>CGRP mAb; requires loading dose</td>
<td>240 mg SC load then 120 mg SC monthly :: SC :: :: 240 mg SC loading dose (2 x 120 mg injections), then 120 mg SC monthly</td>
<td>None</td>
<td>Hypersensitivity</td>
<td>Injection site reactions; vertigo</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Onabotulinumtoxin A (Botox)</td>
<td>IM</td>
<td>Chronic migraine with aura (≥15 days/month); failed oral preventives</td>
<td>155-195 units IM q12wk :: IM :: :: 155-195 units across 31-39 injection sites per PREEMPT protocol; repeat q12 weeks; effect may take 2-3 cycles</td>
<td>None</td>
<td>Infection at injection sites; myasthenia gravis; neuromuscular disorder</td>
<td>Neck weakness; ptosis; antibody formation if loss of effect</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Flunarizine</td>
<td>PO</td>
<td>Calcium channel blocker for prevention; especially hemiplegic migraine</td>
<td>5 mg qHS; 10 mg qHS :: PO :: :: Start 5 mg qHS; may increase to 10 mg qHS; especially useful for hemiplegic migraine (not available in US)</td>
<td>None</td>
<td>Depression; Parkinson's disease; extrapyramidal disorders</td>
<td>Weight gain; depression; parkinsonism with prolonged use</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Lamotrigine</td>
<td>PO</td>
<td>May reduce aura frequency specifically; hemiplegic migraine</td>
<td>25 mg daily; 50 mg BID; 100 mg BID :: PO :: :: Start 25 mg daily; increase by 25 mg q2wk to 50-100 mg BID; SLOW titration to prevent rash</td>
<td>None</td>
<td>History of lamotrigine-related rash; interacting drugs (valproate halves dose)</td>
<td><strong>RASH (stop immediately if rash develops - SJS risk)</strong>; monitor closely during titration</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Acetazolamide</td>
<td>PO</td>
<td>Hemiplegic migraine prevention; familial hemiplegic migraine</td>
<td>250 mg BID; 500 mg BID :: PO :: :: Start 250 mg BID; may increase to 500 mg BID</td>
<td>None</td>
<td>Sulfa allergy; severe hepatic/renal disease; hypokalemia; acidosis</td>
<td>Paresthesias; metabolic acidosis; K+; bicarbonate</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="4-other-recommendations">4. OTHER RECOMMENDATIONS<a class="headerlink" href="#4-other-recommendations" title="Permanent link">&para;</a></h2>
<h3 id="4a-referrals-consults">4A. Referrals &amp; Consults<a class="headerlink" href="#4a-referrals-consults" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neurology/Headache specialist referral for aura characterization, preventive optimization, and differentiation from other neurological conditions</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>OB/GYN consultation for contraceptive counseling - <strong>estrogen-containing contraceptives contraindicated</strong> in migraine with aura due to elevated ischemic stroke risk</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Cardiology referral if TTE shows PFO for discussion of closure in select cases (recurrent cryptogenic stroke or debilitating aura despite medical therapy)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Genetics consultation if hemiplegic migraine suspected for CACNA1A, ATP1A2, SCN1A testing and family counseling</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Physical therapy for cervicogenic component and trigger point management</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Psychology/Behavioral medicine for CBT addressing aura anxiety, attack anticipation, and comorbid mood disorders</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Ophthalmology if visual aura atypical or concern for retinal pathology</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Sleep medicine if sleep disorder contributing to migraine frequency (OSA, insomnia)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<h3 id="4b-patient-instructions">4B. Patient Instructions<a class="headerlink" href="#4b-patient-instructions" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Return immediately for new/different headache, "worst headache of life," or thunderclap onset which may indicate subarachnoid hemorrhage</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Return immediately if aura persists &gt;60 minutes or if new weakness on one side of body develops (need to rule out stroke)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Return immediately for headache with fever, stiff neck, or altered mental status which may indicate CNS infection</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td><strong>AVOID estrogen-containing contraceptives</strong> (combined birth control pills, patch, ring) - use progestin-only methods (mini-pill, Depo-Provera, Mirena IUD, Nexplanon) or non-hormonal methods</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Triptans ARE safe for your typical visual/sensory aura - take at headache onset or when aura ends; do NOT take if you experience weakness (motor aura)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Maintain headache/aura diary tracking aura type, duration, triggers, and medication use to guide treatment optimization</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Limit acute medication use to ≤10 days/month to prevent medication overuse headache which worsens both headache and aura</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Learn your personal aura warning signs and take acute medication promptly when headache begins</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Do not drive or operate machinery during visual or motor aura as vision and coordination may be impaired</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="4c-lifestyle-prevention">4C. Lifestyle &amp; Prevention<a class="headerlink" href="#4c-lifestyle-prevention" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Regular sleep schedule (7-8 hours, consistent bedtime) as sleep changes are a major aura trigger</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Avoid known aura triggers (bright/flashing lights, high altitude, significant sleep deprivation, extreme stress)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Regular aerobic exercise (30 min moderate activity 5x/week) reduces migraine frequency; avoid if currently in aura</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Magnesium-rich diet (leafy greens, nuts, whole grains) or supplementation as magnesium specifically helps aura</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Stress management techniques (mindfulness, biofeedback, relaxation training) as stress is a major trigger</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Adequate hydration (at least 64 oz water daily) as dehydration can trigger attacks</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Smoking cessation to reduce vascular risk, particularly important given aura-associated stroke risk</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Caffeine moderation (≤200 mg/day) and consistent daily intake to avoid withdrawal triggers</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Blood pressure control (target &lt;130/80) given elevated vascular risk with aura</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Avoid high altitude or rapid altitude changes if altitude is a known aura trigger</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="section-b-reference">SECTION B: REFERENCE<a class="headerlink" href="#section-b-reference" title="Permanent link">&para;</a></h2>
<hr />
<h2 id="5-differential-diagnosis">5. DIFFERENTIAL DIAGNOSIS<a class="headerlink" href="#5-differential-diagnosis" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Alternative Diagnosis</th>
<th>Key Distinguishing Features</th>
<th>Tests to Differentiate</th>
</tr>
</thead>
<tbody>
<tr>
<td>Transient ischemic attack (TIA)</td>
<td>Sudden onset (maximal at onset vs gradual aura spread); negative symptoms (vision loss vs positive scintillations); vascular risk factors; older age; duration usually &lt;1 hr</td>
<td>MRI DWI (no restriction in aura); MRA/CTA (no vessel occlusion); aura has visual "march"</td>
</tr>
<tr>
<td>Ischemic stroke</td>
<td>Fixed deficit; sudden onset; vascular territory distribution; risk factors</td>
<td>MRI DWI (shows restriction); CT may be normal early</td>
</tr>
<tr>
<td>Migraine with brainstem aura</td>
<td>Aura includes brainstem symptoms (vertigo, tinnitus, decreased hearing, diplopia, ataxia, dysarthria, decreased LOC)</td>
<td>Clinical criteria; MRI to exclude posterior fossa lesion</td>
</tr>
<tr>
<td>Retinal migraine</td>
<td>Monocular visual symptoms (vs binocular in typical aura); complete vision loss in one eye</td>
<td>Ophthalmology exam; cover/uncover test during symptoms</td>
</tr>
<tr>
<td>Focal seizure with visual phenomena</td>
<td>Shorter duration (seconds to minutes); positive phenomena; may have automatisms; post-ictal confusion</td>
<td>EEG may show epileptiform activity; MRI for structural lesion</td>
</tr>
<tr>
<td>Transient global amnesia</td>
<td>Anterograde amnesia; repetitive questioning; no visual or motor symptoms; resolves &lt;24 hr</td>
<td>Clinical diagnosis; MRI may show hippocampal DWI changes</td>
</tr>
<tr>
<td>Giant cell arteritis</td>
<td>Age &gt;50; scalp tenderness; jaw claudication; visual loss (not scintillations); elevated ESR/CRP</td>
<td>ESR, CRP (elevated); temporal artery biopsy</td>
</tr>
<tr>
<td>Carotid/vertebral dissection</td>
<td>Neck pain; Horner syndrome; pulsatile tinnitus; stroke symptoms</td>
<td>MRA/CTA neck showing dissection</td>
</tr>
<tr>
<td>CADASIL</td>
<td>Migraine with aura often first symptom; subcortical strokes; family history; cognitive decline</td>
<td>MRI shows characteristic WMH (anterior temporal, external capsule); NOTCH3 mutation</td>
</tr>
<tr>
<td>Mitochondrial encephalopathy (MELAS)</td>
<td>Stroke-like episodes not following vascular territory; seizures; elevated lactate; short stature</td>
<td>MRI (non-vascular stroke pattern); genetic testing; muscle biopsy</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="6-monitoring-parameters">6. MONITORING PARAMETERS<a class="headerlink" href="#6-monitoring-parameters" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Parameter</th>
<th>Frequency</th>
<th>Target/Threshold</th>
<th>Action if Abnormal</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aura characteristics (type, duration, frequency)</td>
<td>Each visit; diary</td>
<td>Aura duration &lt;60 min; stable pattern</td>
<td>Prolonged aura needs stroke rule-out; increasing frequency reassess prevention</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Headache days/month</td>
<td>Monthly</td>
<td>&lt;4 headache days/month; 50% reduction on preventive</td>
<td>Escalate therapy if not meeting target; consider CGRP mAb or Botox</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Acute medication use days</td>
<td>Monthly</td>
<td>≤10 days/month</td>
<td>MOH education; consider preventive escalation; may need withdrawal</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Blood pressure</td>
<td>Each visit</td>
<td>&lt;130/80 mmHg</td>
<td>Optimize BP control given elevated vascular risk with aura</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>HIT-6 or MIDAS disability score</td>
<td>Every 3 months</td>
<td>50% improvement or score &lt;50</td>
<td>Escalate preventive therapy if severely disabled</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Topiramate: serum bicarbonate</td>
<td>Baseline, 3 months</td>
<td>&gt;18 mEq/L</td>
<td>Consider dose reduction or switch if metabolic acidosis</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Valproate: LFTs</td>
<td>Baseline, 3 months, then q6mo</td>
<td>AST/ALT &lt;3x ULN</td>
<td>Discontinue if significant elevation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>CGRP mAb: constipation assessment</td>
<td>Each visit</td>
<td>No severe constipation</td>
<td>Add fiber/laxatives; reduce dose or discontinue if severe</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Lamotrigine: rash monitoring</td>
<td>Weekly during titration</td>
<td>No rash</td>
<td><strong>STOP IMMEDIATELY if rash develops</strong> - SJS risk</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
<tr>
<td>Contraceptive status</td>
<td>Each visit (women of reproductive age)</td>
<td>Progestin-only or non-hormonal</td>
<td>Remove estrogen-containing contraceptives; counsel on alternatives</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="7-disposition-criteria">7. DISPOSITION CRITERIA<a class="headerlink" href="#7-disposition-criteria" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Disposition</th>
<th>Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td>Discharge home</td>
<td>Typical aura pattern confirmed; no stroke symptoms; pain controlled; able to tolerate PO; follow-up arranged; contraceptive counseling if needed</td>
</tr>
<tr>
<td>Admit to floor</td>
<td>Prolonged aura (&gt;60 min) requiring observation; status migrainosus requiring IV therapy; first aura with abnormal imaging requiring further workup; hemiplegic migraine with prolonged weakness</td>
</tr>
<tr>
<td>Admit to ICU</td>
<td>Migrainous infarction (stroke occurring during typical aura); hemodynamic instability; severe refractory status migrainosus requiring ketamine infusion</td>
</tr>
<tr>
<td>Transfer to higher level</td>
<td>Stroke mimicking aura requiring thrombectomy evaluation; complex hemiplegic migraine requiring tertiary headache center</td>
</tr>
<tr>
<td>Outpatient follow-up</td>
<td>New diagnosis: 2-4 weeks; Stable on prevention: 3-6 months; After preventive change: 4-8 weeks</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="8-evidence-references">8. EVIDENCE &amp; REFERENCES<a class="headerlink" href="#8-evidence-references" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th>Evidence Level</th>
<th>Source</th>
</tr>
</thead>
<tbody>
<tr>
<td>Migraine with aura increases ischemic stroke risk, especially in women using combined oral contraceptives</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/15647264/">Etminan et al. BMJ 2005</a></td>
</tr>
<tr>
<td>ACOG: Combined hormonal contraceptives contraindicated in migraine with aura</td>
<td>Class I (Guideline)</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/31568397/">ACOG Practice Bulletin 2019</a></td>
</tr>
<tr>
<td>Triptans safe and effective in migraine with typical aura</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/25600718/">Marmura et al. Headache 2015</a></td>
</tr>
<tr>
<td>Triptans contraindicated in hemiplegic migraine (expert consensus)</td>
<td>Class III, Level C</td>
<td>Expert consensus; <a href="https://pubmed.ncbi.nlm.nih.gov/29368949/">IHS Classification ICHD-3 2018</a></td>
</tr>
<tr>
<td>Magnesium particularly effective for migraine with aura prevention</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/8792038/">Peikert et al. Cephalalgia 1996</a></td>
</tr>
<tr>
<td>Lamotrigine may reduce aura frequency specifically</td>
<td>Class II, Level C</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/16087905/">Lampl et al. Neurology 2005</a></td>
</tr>
<tr>
<td>Topiramate effective for migraine prevention</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/15096395/">Silberstein et al. Arch Neurol 2004</a></td>
</tr>
<tr>
<td>Propranolol effective for migraine prevention</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/15106218/">Linde et al. Cochrane 2004</a></td>
</tr>
<tr>
<td>CGRP monoclonal antibodies effective for prevention</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/29171821/">Goadsby et al. NEJM 2017 (erenumab STRIVE)</a></td>
</tr>
<tr>
<td>Gepants safe in patients with cardiovascular contraindications to triptans</td>
<td>Class I, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/31742631/">Dodick et al. JAMA 2019 (ubrogepant ACHIEVE I)</a></td>
</tr>
<tr>
<td>Lasmiditan (ditan) does not have cardiovascular contraindications</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/30091160/">Kuca et al. Headache 2018</a></td>
</tr>
<tr>
<td>IV magnesium effective for acute migraine with aura</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/11903546/">Bigal et al. Headache 2002</a></td>
</tr>
<tr>
<td>Aura duration &gt;60 minutes warrants stroke evaluation</td>
<td>Class III, Level C</td>
<td>Expert consensus; <a href="https://pubmed.ncbi.nlm.nih.gov/15147249/">Lipton et al. Headache 2004</a></td>
</tr>
<tr>
<td>PFO closure may benefit select patients with migraine with aura</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/28359515/">Tobis et al. JACC 2017 (RESPECT trial long-term)</a></td>
</tr>
<tr>
<td>Acetazolamide effective for familial hemiplegic migraine</td>
<td>Class III, Level C</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/10489058/">Battistini et al. Neurology 1999</a></td>
</tr>
<tr>
<td>Verapamil may be used acutely in hemiplegic migraine</td>
<td>Class III, Level C</td>
<td>Expert consensus; <a href="https://pubmed.ncbi.nlm.nih.gov/15836583/">Mathew et al. Headache 2005</a></td>
</tr>
<tr>
<td>OnabotulinumtoxinA effective for chronic migraine</td>
<td>Class I, Level A</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/20487038/">Dodick et al. Headache 2010 (PREEMPT pooled)</a></td>
</tr>
<tr>
<td>Exercise as effective as topiramate for migraine prevention</td>
<td>Class II, Level B</td>
<td><a href="https://pubmed.ncbi.nlm.nih.gov/21816772/">Varkey et al. Cephalalgia 2011</a></td>
</tr>
</tbody>
</table>
<hr />
<h2 id="change-log">CHANGE LOG<a class="headerlink" href="#change-log" title="Permanent link">&para;</a></h2>
<p><strong>v1.0 (January 27, 2026)</strong>
- Initial template creation
- Comprehensive coverage of migraine with aura including typical and hemiplegic subtypes
- Strong emphasis on aura vs TIA/stroke differentiation
- Contraceptive counseling guidance (estrogen contraindicated)
- Hemiplegic migraine-specific treatment considerations (no triptans/ergots)
- CGRP antagonists and ditans for cardiovascular-safe options
- PubMed-linked citations throughout
- Structured dosing format for order sentence generation</p>
<hr />
<h2 id="appendix-a-aura-types-and-characteristics">APPENDIX A: Aura Types and Characteristics<a class="headerlink" href="#appendix-a-aura-types-and-characteristics" title="Permanent link">&para;</a></h2>
<h3 id="typical-aura-features-ichd-3-criteria">Typical Aura Features (ICHD-3 Criteria)<a class="headerlink" href="#typical-aura-features-ichd-3-criteria" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Aura Type</th>
<th>Characteristics</th>
<th>Duration</th>
<th>Positive/Negative Symptoms</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Visual</strong> (most common ~90%)</td>
<td>Scintillating scotoma, fortification spectra (zigzag lines), photopsia (flashes), spreading across visual field</td>
<td>5-60 min</td>
<td>Positive (flashes, lines) then negative (scotoma)</td>
</tr>
<tr>
<td><strong>Sensory</strong> (~30%)</td>
<td>Paresthesias (pins/needles) typically starting in hand, spreading up arm, then to face/tongue</td>
<td>5-60 min</td>
<td>Positive (tingling) may be followed by numbness</td>
</tr>
<tr>
<td><strong>Language/Speech</strong> (~10%)</td>
<td>Dysphasia, word-finding difficulty, paraphasic errors</td>
<td>5-60 min</td>
<td>Negative (difficulty speaking)</td>
</tr>
<tr>
<td><strong>Motor</strong> (hemiplegic migraine)</td>
<td>Unilateral weakness involving arm and/or leg</td>
<td>Minutes to days</td>
<td>Negative (weakness); TRIPTANS CONTRAINDICATED</td>
</tr>
</tbody>
</table>
<h3 id="visual-aura-march-pattern">Visual Aura "March" Pattern<a class="headerlink" href="#visual-aura-march-pattern" title="Permanent link">&para;</a></h3>
<p>The classic visual aura demonstrates a characteristic march:
1. <strong>Starts</strong> as small flickering spot near center of vision
2. <strong>Expands</strong> outward with scintillating (zigzag, fortress-like) border
3. <strong>Leaves</strong> scotoma (blind spot) in its wake
4. <strong>Duration</strong> typically 20-30 minutes
5. <strong>Followed by</strong> headache within 60 minutes (usually)</p>
<p><strong>Key Differentiator from Stroke:</strong> Aura symptoms SPREAD gradually over 5+ minutes; stroke symptoms are maximal at onset.</p>
<h3 id="hemiplegic-migraine-special-considerations">Hemiplegic Migraine Special Considerations<a class="headerlink" href="#hemiplegic-migraine-special-considerations" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Feature</th>
<th>Management Implication</th>
</tr>
</thead>
<tbody>
<tr>
<td>Motor weakness present</td>
<td><strong>NO TRIPTANS, NO ERGOTS</strong> - potential vasoconstriction risk</td>
</tr>
<tr>
<td>Weakness may last hours to days</td>
<td>Requires stroke rule-out; observation may be needed</td>
</tr>
<tr>
<td>Familial form (FHM)</td>
<td>Genetic counseling; CACNA1A, ATP1A2, SCN1A testing</td>
</tr>
<tr>
<td>May have brainstem symptoms</td>
<td>Consider migraine with brainstem aura overlap</td>
</tr>
<tr>
<td>Prevention</td>
<td>Verapamil, flunarizine, acetazolamide preferred; avoid beta-blockers in FHM type 1</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="appendix-b-contraceptive-guidance-for-migraine-with-aura">APPENDIX B: Contraceptive Guidance for Migraine with Aura<a class="headerlink" href="#appendix-b-contraceptive-guidance-for-migraine-with-aura" title="Permanent link">&para;</a></h2>
<h3 id="why-estrogen-is-contraindicated">Why Estrogen is Contraindicated<a class="headerlink" href="#why-estrogen-is-contraindicated" title="Permanent link">&para;</a></h3>
<ul>
<li>Migraine with aura increases ischemic stroke risk 2-4x baseline</li>
<li>Estrogen-containing contraceptives increase stroke risk 2-4x</li>
<li><strong>Combined risk: 6-8x increased stroke risk</strong> (multiplicative)</li>
<li>Risk highest in women who smoke or have other vascular risk factors</li>
</ul>
<h3 id="safe-contraceptive-options">Safe Contraceptive Options<a class="headerlink" href="#safe-contraceptive-options" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Method</th>
<th>Type</th>
<th>Notes</th>
</tr>
</thead>
<tbody>
<tr>
<td>Copper IUD (Paragard)</td>
<td>Non-hormonal</td>
<td>Highly effective; no hormone exposure</td>
</tr>
<tr>
<td>Levonorgestrel IUD (Mirena, Liletta)</td>
<td>Progestin-only</td>
<td>Minimal systemic absorption; highly effective</td>
</tr>
<tr>
<td>Progestin-only pill (mini-pill)</td>
<td>Progestin-only</td>
<td>Must take at same time daily; less effective than combined</td>
</tr>
<tr>
<td>Depo-Provera</td>
<td>Progestin-only</td>
<td>IM injection q3 months</td>
</tr>
<tr>
<td>Nexplanon (etonogestrel implant)</td>
<td>Progestin-only</td>
<td>3-year subdermal implant; highly effective</td>
</tr>
<tr>
<td>Condoms, diaphragm</td>
<td>Barrier</td>
<td>No hormones; less effective</td>
</tr>
</tbody>
</table>
<h3 id="contraceptives-to-avoid">Contraceptives to AVOID<a class="headerlink" href="#contraceptives-to-avoid" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Method</th>
<th>Why Contraindicated</th>
</tr>
</thead>
<tbody>
<tr>
<td>Combined oral contraceptives (COCs)</td>
<td>Contains estrogen - elevated stroke risk</td>
</tr>
<tr>
<td>Contraceptive patch (Xulane)</td>
<td>Contains estrogen</td>
</tr>
<tr>
<td>Vaginal ring (NuvaRing)</td>
<td>Contains estrogen</td>
</tr>
</tbody>
</table>
<h3 id="counseling-points">Counseling Points<a class="headerlink" href="#counseling-points" title="Permanent link">&para;</a></h3>
<ol>
<li>Document contraceptive method and provide alternatives</li>
<li>If patient is on estrogen, counsel on immediate discontinuation</li>
<li>Refer to OB/GYN for contraceptive transition</li>
<li>Discuss emergency contraception options (progestin-only preferred)</li>
<li>Address pregnancy planning if relevant</li>
</ol>







  
  






                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        
<div class="md-social">
  
    
    
    
    
      
      
    
    <a href="https://github.com/blondarb/neuro-plans" target="_blank" rel="noopener" title="github.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      
      <script id="__config" type="application/json">{"annotate": null, "base": "../..", "features": ["navigation.instant", "navigation.tracking", "navigation.sections", "navigation.expand", "navigation.top", "search.suggest", "search.highlight", "content.code.copy"], "search": "../../assets/javascripts/workers/search.2c215733.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../../assets/javascripts/bundle.79ae519e.min.js"></script>
      
        <script src="../../assets/js/comments.js"></script>
      
    
  </body>
</html>